Financing, Equity Private Placements
CereVasc, Inc.
05/24
|
$70.0 Million
![CereVasc](/sites/default/files/images/custom/cerevasc.png)
![Bain](/sites/default/files/images/custom/baincls.png)
![Xontogeny](/sites/default/files/images/custom/xontogeny.png)
Piper Sandler served as sole financial advisor for CereVasc, Inc. on a Series B Financing from Bain Capital Life Sciences and Perceptive Xontogeny Venture Fund (PXV)